AlphaMadera's AlphaVal page computes Sempra's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag SRE as undervalued, fairly valued, or overvalued.

What is Sempra's fair value?

Fair value for SRE is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value SRE?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from SRE's most recent reported fundamentals.

SRE - Sempra

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $106.20 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 85% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Moderate

Trading 29.0% above fair value

Current Price $92.80

Bear Case $62.94 32.2% downside ($62.94 - $92.80) / $92.80 = -32.2% $3.78 × 14x P/E

Fair Value $71.94 22.5% downside ($71.94 - $92.80) / $92.80 = -22.5% $3.78 × 16x P/E

Bull Case $80.93 12.8% downside ($80.93 - $92.80) / $92.80 = -12.8% $3.78 × 18x P/E

Adjust Assumptions

P/E Multiple

16.0x

Adjusted EPS

3.78$

Key Value Driver

Normalized P/E multiple (16x base case)

Implied Market Multiple 24.5x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $106.20 from 26 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $71.94 per share.

Warnings

⚠ The company's reported profits differ from official accounting profits by 38%. Check what costs are being left out of the adjusted number.

⚠ The company pays out 95% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.

ℹ Wall Street's average price target is $106.20 (from 26 analysts). Our estimate is 43% below the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples